The PBC Journey: Learning
Newly diagnosed? Read the latest insights on what to expect next.
-
-
PBC and the immune system: insights into autoimmunity
-
Ascletis drops potential PBC therapy following phase 2 data
-
Pruritus under-documented for patients with PBC
-
EMA accepts MAA for CymaBay’s PBC therapy
-
FDA accepts sNDA for Ocaliva for the treatment of PBC
-
Phase 3 trial shows elafibranor safe and effective in PBC
